Skip to content
10-Q

Quarterly Report

ALIMERA SCIENCES, INC.

0001267602-24-000032

← back to feed
Filed
May 14, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2024 · May 9, 2024 52.39M sh
Shares Diluted Q1 2024 · Mar 31, 2024 54.36M sh
Shares Diluted Q1 2024 · Mar 31, 2023 7.03M sh
Capex Q1 2024 · Mar 31, 2024 $21K
Capex Q1 2024 · Mar 31, 2023 $9K
Operating Cash Flow Q1 2024 · Mar 31, 2024 −$566K
Operating Cash Flow Q1 2024 · Mar 31, 2023 −$2.21M
Cash And Equivalents Q1 2024 · Mar 31, 2024 $14.31M
Cash And Equivalents Q1 2024 · Dec 31, 2023 $12.06M
Stockholders Equity Q1 2024 · Mar 31, 2024 $40.65M
Stockholders Equity Q1 2024 · Dec 31, 2023 $46.17M
Stockholders Equity Q1 2024 · Mar 31, 2023 −$18.92M
Stockholders Equity Q1 2024 · Dec 31, 2022 −$20.81M
Current Liabilities Q1 2024 · Mar 31, 2024 $20.79M
Current Liabilities Q1 2024 · Dec 31, 2023 $21.91M
Total Liabilities Q1 2024 · Mar 31, 2024 $111.83M
Total Liabilities Q1 2024 · Dec 31, 2023 $107.35M
Current Assets Q1 2024 · Mar 31, 2024 $54.47M
Current Assets Q1 2024 · Dec 31, 2023 $52.42M
Total Assets Q1 2024 · Mar 31, 2024 $152.49M
Total Assets Q1 2024 · Dec 31, 2023 $153.52M
Eps Diluted Q1 2024 · Mar 31, 2024 −$0.12
Eps Diluted Q1 2024 · Mar 31, 2023 −$0.71
Eps Basic Q1 2024 · Mar 31, 2024 −$0.12
Eps Basic Q1 2024 · Mar 31, 2023 −$0.71
Sga Expense Q1 2024 · Mar 31, 2024 $5.43M
Sga Expense Q1 2024 · Mar 31, 2023 $4.17M
Rd Expense Q1 2024 · Mar 31, 2024 $4.36M
Rd Expense Q1 2024 · Mar 31, 2023 $4.16M
Net Income Q1 2024 · Mar 31, 2024 −$6.25M
Net Income Q1 2024 · Mar 31, 2023 −$4.97M
Operating Income Q1 2024 · Mar 31, 2024 −$2.3M
Operating Income Q1 2024 · Mar 31, 2023 −$3.3M
Gross Profit Q1 2024 · Mar 31, 2024 $19.66M
Gross Profit Q1 2024 · Mar 31, 2023 $11.52M
Revenue Q1 2024 · Mar 31, 2024 $23.01M
Revenue Q1 2024 · Mar 31, 2023 $13.55M
Stock Repurchased Q1 2024 · Mar 31, 2023 $314K